Dr Jyoti Anand Kode
Associate Professor
Homi Bhabha National Institute, Mumbai
(2021)
Maharashtra
Expertise:
Immunology
40
Publications
0
Projects
833
Scopus Citations
736
CrossRef
12 Years 3 Months Total Experience
Scopus
833
Citations
13
h-index
CrossRef
736
Citations
12
h-index
Google Scholar
Loading Scholar statistics...
Professional Recognition
No Data Found
There is currently nothing to display here.
Community & Membership
IC-SCR Reliance Life Sciences
Invited Expert in Stem Cell BiologyIC-SCR KEM Hospital
Invited Expert in Stem Cell BiologyACTREC Alumni Association
Secretary, Executive CommitteeACTREC Alumni Association
Secretary, Executive CommitteeIndian Association of Cancer Research
Life MemberMumbai Immunology Group
Member, Executive CommitteeMumbai Immunology Group
Life memberIndian Immunology Society
Life memberMumbai Hematology Group
Life memberImmuno-Oncology Society of India
Life memberIndian Association of Cancer Research
Life memberGlobal Cancer Consortium South Asia Chapter
AnnualPersonal Details
Doctor of Philosophy
1990
N/A
Master of Science
1987
N/A
Bachelor of Science
1985
N/A
Associate Professor
Aug 2021 – —
Homi Bhabha National Institute, Mumbai
Principal Investigator
Sep 2021 – Sep 2025
Advanced Centre for Treatment, Research and Education in Cancer
Scientific Officer G
Jul 2020 – Sep 2025
Advanced Centre for Treatment, Research and Education in Cancer
| Cancer Research Institute
Assistant Professor
May 2016 – Aug 2021
Homi Bhabha National Institute, Mumbai
Scientific Officer F
Jul 2013 – Jun 2020
Advanced Centre for Treatment, Research and Education in Cancer
Medical and Health Sciences
Scholarly Work
No Data Found
There is currently nothing to display here.
CD26 and adenosine signaling pathway molecules as regulators of immune reconstitution in human hematopoietic stem cell transplantation
Critical analysis of Dravya acting on Rakta Dhatu along with their applicability in Leukaemia through In silico and Cell Line studies
A method of obtaining bone marrow MSC (BM-MSC) and a conditioned media therefrom having therapeutic potential
Advanced Centre for Treatment
Research
& Education in Cancer (ACTREC)
Tata Memorial Centre
Tata Memorial Centre
Kharghar
Navi Mumbai 410210
India
-
Application No. :
202521091215
Filed :
23-09-2025
Published :
30-11--0001
Filed
Immune modulating therapy using UC-MSC-CM to inhibit tumor growth
1] Advanced Centre for Treatment
Research & Education in Cancer
(ACTREC)
Tata Memorial Centre. Kharghar
Navi Mumbai 410210
India. 2] OCT Therapies Pvt Ltd
3 Nimbkar Society
Malabar Hill Road
Mulund Colony
Mulund West
Mumbai 400082
India.
-
Application No. :
PCT/IN2025/051444
Filed :
05-09-2025
Published :
30-11--0001
Filed
Immune modulating therapy using UC-MSC-CM to inhibit tumor growth.
1] Advanced Centre for Treatment
Research & Education in Cancer
(ACTREC)
Tata Memorial Centre. Kharghar
Navi Mumbai 410210
India. 2] OCT Therapies Pvt Ltd
3 Nimbkar Society
Malabar Hill Road
Mulund Colony
Mulund West
Mumbai 400082
India.
-
Patent No. :
Indian Patent # 570565
Filed :
17-09-2024
Published :
11-09-2025
Granted
An establishment and characterization of an oral cancer cell line model of Indian origin ‘TBM-02’ and applications thereof
Advanced Centre for Treatment
Research
& Education in Cancer (ACTREC)
Tata Memorial Centre
Tata Memorial Centre
Kharghar
Navi Mumbai 410210
India
-
Application No. :
202421061738
Filed :
14-08-2024
Published :
18-07-2025
Published
ANTI-CANCER AND IMMUNOMODULATORY COMPOSITION
1] Central Salt & Marine Chemicals Research Institute (CSMCRI)
Bhavnagar
Gujarat 364002 and 2] Advanced Centre for Treatment
Research
& Education in Cancer (ACTREC)
Tata Memorial Centre
Tata Memorial Centre
Kharghar
Navi Mumbai 410210
India.
-
Application No. :
202311057434
Filed :
25-08-2023
Published :
28-02-2025
Published
Standardized Garcinia fruit juice (GI and GX) exhibit efficacy in immunocompetent mice model for treatment of acute graft-versus-host disease by regulating innate immune mechanisms post allogeneic hematopoietic stem cell transplantation
1] Advanced Centre for Treatment
Research & Education in Cancer
(ACTREC)
Tata Memorial Centre. Kharghar
Navi Mumbai
India. 2] ICAR-Directorate of Medicinal and Aromatic Plants Research
Boriavi-387310
Anand
Gujarat
India.
-
Application No. :
202221060383
Filed :
21-10-2022
Published :
08-05-2024
Published
Standardized fruit rind extract of Garcinia exhibiting growth inhibition of triple-negative breast cancer in pre-clinical animal model
1] ICAR-Directorate of Medicinal and Aromatic Plants Research
Boriavi-387310
Anand
Gujarat
India. 2] Advanced Centre for Treatment
Research & Education in Cancer
(ACTREC)
Tata Memorial Centre. Kharghar
Navi Mumbai
India.
-
Application No. :
202221018336
Filed :
29-03-2022
Published :
26-07-2023
Published
Extracts and purified phytochemicals from Garcinia species exhibiting cytotoxicity against human colon cancer
ICAR-Directorate of Medicinal and Aromatic Plants Research
Boriavi-387310
Anand
Gujarat (India)
-
Application No. :
202121059785
Filed :
21-12-2021
Published :
19-07-2023
Published
A synergistic polyherbal formulation exhibiting potential anti-cancer activity.
CSIR- Unit for Research and Development of Information Products (URDIP)
-
Application No. :
202111001172
Filed :
11-01-2021
Published :
23-09-2022
Published
Use of 3, 3’-Diselenodipropionic acid (DSEPA) as an anticancer agent.
Secretary
Department of Atomic Energy
Government of India
-
Patent No. :
US Patent # 11,213,499 B1
Filed :
26-08-2020
Published :
04-01-2022
Granted
Scholarly Publications
Immunoprecipitation of mycobacterial antigens with sera from patients with leprosy
Limiting dilution analysis of proliferating and cytotoxic lymphocytes in the peripheral blood and tumours of oral cancer patients
Ability of lymphokine-activated killer cells to lyse mycobacteria- infected cells
Scopus: 1
Mesenchymal Stromal Cells and Their Clinical Applications
T-cell receptor γ and δ gene rearrangements in T-cell acute lymphoblastic leukemia in Indian patients
Clonal T-cell receptor γ and δ gene rearrangements in T-cell acute lymphoblastic leukemia at diagnosis: Predictor of prognosis and response to chemotherapy
T-cell receptor γ and δ junctional gene rearrangements as diagnostic and prognostic biomarker for T-cell acute lymphoblastic leukemia [10]
Mesenchymal stem cells: Immunobiology and role in immunomodulation and tissue regeneration
Showing 1 to 8 of 40 publications